133 related articles for article (PubMed ID: 3488019)
1. In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
Jorgensen JH; Redding JS; Howell AW
Antimicrob Agents Chemother; 1986 May; 29(5):921-2. PubMed ID: 3488019
[TBL] [Abstract][Full Text] [Related]
2. Roxithromycin alone and in combination with sulphamethoxazole against Haemophilus influenzae.
Lapointe JR; Lavallée C; Meilleur R; Bourget C
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():21-9. PubMed ID: 3501425
[TBL] [Abstract][Full Text] [Related]
3. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
4. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
Kuenzi B; Segessenmann C; Gerber AU
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
[TBL] [Abstract][Full Text] [Related]
5. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
6. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
[TBL] [Abstract][Full Text] [Related]
8. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay.
Pankuch GA; Hoellman DB; Lin G; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Nov; 42(11):3032-4. PubMed ID: 9797250
[TBL] [Abstract][Full Text] [Related]
9. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
Bergeron MG; Lavoie GY; Boucher FD
J Antimicrob Chemother; 1987 Nov; 20(5):663-9. PubMed ID: 3501422
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
Barlam T; Neu HC
Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
[TBL] [Abstract][Full Text] [Related]
11. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
Credito KL; Lin G; Pankuch GA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
[TBL] [Abstract][Full Text] [Related]
12. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of nasopharyngeal isolates of Haemophilus influenzae from healthy children in day-care centres: results of multicentre study in Russia.
Stratchounski LS; Kretchikova OI; Reshedko GK; Stetsiouk OU; Kandalov MM; Egorova OA; Boyko LM; Ryabkova EL; Tarasova GD; Blokhin BM
Int J Antimicrob Agents; 2001 Oct; 18(4):347-51. PubMed ID: 11691567
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of roxithromycin against respiratory and skin pathogens.
Pechére JC; Auckenthaler R
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
Walsh F; Carnegy F; Willcock J; Amyes S
J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
[TBL] [Abstract][Full Text] [Related]
16. Activities of HMR 3787 and RU 64399 compared with those of four other agents against Haemophilus influenzae and Haemophilus parainfluenzae.
Bozdogan B; Clark C; Bryskier A; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Jan; 47(1):405-7. PubMed ID: 12499225
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing of Haemophilus influenzae to clarithromycin.
Paton R; Arnold J; Cockburn J; Emmanuel FX
J Antimicrob Chemother; 2000 Apr; 45(4):529-31. PubMed ID: 10747833
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of fluoroquinolones, macrolides, and imipenem resistance in Haemophilus influenzae: analysis of the mutations in QRDRs and assessment of the extent of the AcrAB-TolC-mediated resistance.
Cherkaoui A; Gaïa N; Baud D; Leo S; Fischer A; Ruppe E; François P; Schrenzel J
Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2201-2210. PubMed ID: 30145620
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.
Fernandes PB; Hardy D; Bailer R; McDonald E; Pintar J; Ramer N; Swanson R; Gade E
Antimicrob Agents Chemother; 1987 Aug; 31(8):1243-50. PubMed ID: 2957954
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
